Innoviva, Inc. (INVA)
21.08
+0.31
(+1.49%)
USD |
NASDAQ |
Sep 01, 10:56
Innoviva Cash and Short Term Investments (Quarterly) : 579.06M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 579.06M |
| March 31, 2026 | 611.93M |
| December 31, 2025 | 566.67M |
| September 30, 2025 | 533.10M |
| June 30, 2025 | 497.73M |
| March 31, 2025 | 446.88M |
| December 31, 2024 | 412.50M |
| September 30, 2024 | 260.63M |
| June 30, 2024 | 217.00M |
| March 31, 2024 | 178.36M |
| December 31, 2023 | 193.51M |
| September 30, 2023 | 180.00M |
| June 30, 2023 | 173.02M |
| March 31, 2023 | 144.05M |
| December 31, 2022 | 291.05M |
| September 30, 2022 | 301.07M |
| June 30, 2022 | 283.58M |
| March 31, 2022 | 216.80M |
| December 31, 2021 | 201.52M |
| September 30, 2021 | 135.12M |
| June 30, 2021 | 43.26M |
| March 31, 2021 | 282.89M |
| December 31, 2020 | 246.49M |
| September 30, 2020 | 479.19M |
| June 30, 2020 | 417.15M |
| Date | Value |
|---|---|
| March 31, 2020 | 383.95M |
| December 31, 2019 | 350.84M |
| September 30, 2019 | 297.20M |
| June 30, 2019 | 249.66M |
| March 31, 2019 | 192.18M |
| December 31, 2018 | 114.91M |
| September 30, 2018 | 55.48M |
| June 30, 2018 | 107.54M |
| March 31, 2018 | 56.46M |
| December 31, 2017 | 129.08M |
| September 30, 2017 | 168.19M |
| June 30, 2017 | 135.63M |
| March 31, 2017 | 169.81M |
| December 31, 2016 | 150.43M |
| September 30, 2016 | 148.97M |
| June 30, 2016 | 153.87M |
| March 31, 2016 | 168.19M |
| December 31, 2015 | 187.28M |
| September 30, 2015 | 206.19M |
| June 30, 2015 | 229.26M |
| March 31, 2015 | 251.14M |
| December 31, 2014 | 240.50M |
| September 30, 2014 | 268.71M |
| June 30, 2014 | 348.71M |
| March 31, 2014 | 370.92M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Zevra Therapeutics, Inc. | 221.57M |
| Collegium Pharmaceutical, Inc. | 149.32M |
| CorMedix, Inc. | 257.35M |
| ANI Pharmaceuticals, Inc. | 375.87M |
| Corcept Therapeutics, Inc. | 308.20M |